Scholar Rock Holding Corporation
General ticker "SRRK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.7B (TTM average)
Scholar Rock Holding Corporation follows the US Stock Market performance with the rate: 21.6%.
Estimated limits based on current volatility of 4.0%: low 41.59$, high 44.57$
Factors to consider:
- Total employees count: 196 (+30.7%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Operational and conduct risks, Labor/talent shortage/retention, Intellectual property risks, Strategic risks and growth management
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [18.54$, 52.08$]
- 2025-12-31 to 2026-12-31 estimated range: [10.29$, 30.27$]
Financial Metrics affecting the SRRK estimates:
- Negative: with PPE of -17.9 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -4.60 <= 0.33
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 77.62 > 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
Short-term SRRK quotes
Long-term SRRK plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $33.19MM | $0.00MM | $0.00MM |
| Operating Expenses | $167.56MM | $171.29MM | $252.05MM |
| Operating Income | $-134.37MM | $-171.29MM | $-252.05MM |
| Non-Operating Income | $-0.13MM | $5.51MM | $5.76MM |
| R&D Expense | $124.44MM | $121.90MM | $184.55MM |
| Income(Loss) | $-134.50MM | $-165.79MM | $-246.29MM |
| Profit(Loss)* | $-134.50MM | $-165.79MM | $-246.29MM |
| Stockholders Equity | $260.24MM | $225.22MM | $368.63MM |
| Assets | $358.17MM | $311.04MM | $474.92MM |
| Operating Cash Flow | $-132.69MM | $-145.23MM | $-200.95MM |
| Capital expenditure | $1.06MM | $0.07MM | $0.10MM |
| Investing Cash Flow | $-171.70MM | $41.14MM | $-76.06MM |
| Financing Cash Flow | $194.83MM | $102.57MM | $353.03MM |
| Earnings Per Share** | $-2.26 | $-2.18 | $-2.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.